ILMN

NASDAQ

Illumina, Inc. · Healthcare · Life Sciences Tools & Services

Earnings call summary →

—

Loading quote…

Highlights

Market Cap

$21.67B

PE Ratio

23.1976

EV to Ebitda

17.4236

Earnings Yield

4.31%

Revenue (TTM)

$4.34B

Net Income (TTM)

$850.0M

Revenue (Annual YoY Growth)

-0.44%

Revenue (Quarterly YoY Growth)

5.07%

Profit Margin

19.58%

Return on Equity

35.12%

Debt to Equity Ratio

0.9376

Dividend Yield

0.00%

All fundamentals

Core10 fields›

Market Cap$21.67B

Revenue TTM$4.34B

Shares Outstanding152.9M

Float158104864

Float Short4.80%

Days To Cover5.0588786103

Short Interest7086077.0

Insider Ownership4.49%

Relative Strength70.5

GARP2104

Growth Estimates17 fields›

Revenue Growth (Annual)-0.44%

Revenue Growth (Quarterly YoY)5.07%

Operating Revenue Growth (Annual)0.042946

Operating Revenue Growth (Quarterly YoY)-0.011473

3-Year Revenue Growth-1.82%

5-Year Revenue Growth6.02%

EPS Growth (Annual)170.84%

EPS Growth (Quarterly YoY)85.56%

3-Year EPS Growth Rate0.00%

5-Year EPS Growth Rate4.22%

LT EPS Growth Estimates7.35%

EBITDA Growth (Annual)53.45%

EBITDA Growth (Quarterly YoY)18.68%

CFO Growth (Annual)28.91%

CFO Growth (Quarterly YoY)-11.81%

FCF Growth (Annual)46.66%

FCF Growth (Quarterly YoY)-21.49%

Operations28 fields›

Revenue TTM$4.34B

Gross Margin TTM67.08%

Gross Margin (Quarterly)67.07%

R&D % of Revenue TTM21.88%

R&D Expenses TTM$950.0M

Operating Margin TTM20.59%

Operating Margin (Quarterly)22.16%

Operating Expenses TTM$2.02B

Profit Margin TTM19.58%

Profit Margin (Quarterly)28.79%

Net Income TTM$850.0M

EPS TTM5.4635

EPS (Quarterly)2.1688

EBIT Margin TTM20.59%

EBIT Margin (Quarterly)22.16%

EBITDA Margin TTM26.84%

EBITDA Margin (Quarterly)27.93%

EBITDA TTM$1.17B

CFO % of Revenue TTM24.87%

CFO % of Revenue (Quarterly)27.67%

CFO TTM$1.08B

Cash Margin23.29%

Capex % of Revenue TTM3.64%

Capital Expenditures$158.0M

FCF % of Revenue TTM21.23%

FCF % of Revenue (Quarterly)22.67%

FCF TTM$921.0M

Fundamental Score6

Efficiency6 fields›

ROE35.12%

ROA13.54%

ROIC16.96%

CROCI18.38%

Stock Comp % (Quarterly)5.43%

Stock Comp % TTM6.34%

Valuation20 fields›

P/E (TTM)23.1976

P/E Forward24.7659

P/E Ex-Cash21.2428

P/S Forward4.273

PEG Forward-4.0746

P/CFO18.3239

P/FCF21.4674

EV/EBITDA (TTM)17.4236

EV/EBITDA Forward14.509

EV/Revenues (TTM)4.676

EV/Revenues Forward4.4758

EV/CFO19.4509

EV/FCF (TTM)22.0397

Price To Book7.1166

Price to Tangible Book66.7579

Earnings Yield4.31%

FCF Yield4.66%

Dividend Yield0.00%

Payout Ratio0.00%

Value Score3

Relative to Industry11 fields›

Relative Gross Margin (Quarterly)1.5943

Relative Profit Margin (Quarterly)2.2156

Relative P/E0.9075

Relative P/S1.1403

Relative P/B2.0384

Relative Earnings Yield1.1019

Relative Dividend Yield0

Relative ROE2.3954

Relative ROA1.874

Relative ROIC1.9299

Relative Debt to Equity1.4929

Liquidity15 fields›

Cash Per Share10.6732

Current Ratio2.0751

Cash & ST Assets$1.63B

Total Debt$2.48B

Goodwill & Intangibles$1.32B

Total Assets$6.64B

Total Liabilities$3.92B

Shareholders Equity$2.72B

Debt to Equity0.9376

Debt to Assets38.43%

Interest Expense$101.0M

Times Interest Earned8.8515

CFO to Debt (TTM)0.4164

Debt to EBITDA (TTM)2.2242

Goodwill % of Assets19.91%

Yields5 fields›

Dividend Yield0.00%

Payout Ratio0.00%

Earnings Yield4.31%

Buyback Yield3.60%

Shareholder Yield3.60%

Options Flow8 fields›

Call Volume1165

Put Volume101

Put/Call Ratio0.08669527896995709

Call $ Volume844179

Put $ Volume68551

Put/Call $ Ratio0.08120434173321062

Call OI14580

Put OI8042